Aktiesnakken — Juni 2011
-
masha jeg har været i gang ved 34,35
-
vi ser....og Thure endnu engang enig
-
men lad os nu se om en commonsense breakup valuation af selskabet ikke er et ok udgangspunkt for en bund
-
tydeligvis ikke...
-
ikke nødvendigvis i og med at den må anses for den absolut konservative måde at lave valuering på i et biotek
-
normalt laver man estimater på baggrund af pipeline. Men det punkt fjernede vi os fra i kurs 116
-
er I stadig forelskede i Satair?
-
uden at forklejne Zealand så siger dette vel alt om hvor sløjt det står til i biotekbranchen
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind